CONMED Corporation (CNMD) - Total Liabilities
Based on the latest financial reports, CONMED Corporation (CNMD) has total liabilities worth $1.30 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CONMED Corporation liquidity resilience to evaluate the company's liquid asset resilience ratio.
CONMED Corporation - Total Liabilities Trend (1986–2025)
This chart illustrates how CONMED Corporation's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see CNMD asset base.
CONMED Corporation Competitors by Total Liabilities
The table below lists competitors of CONMED Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Changsha DIALINE New Material Sci & Tech Co Ltd
SHE:300700
|
China | CN¥848.12 Million |
|
Fujian Nebula Electronics Co Ltd
SHE:300648
|
China | CN¥1.74 Billion |
|
Malaysia Building Society Bhd
KLSE:1171
|
Malaysia | RM59.36 Billion |
|
Reysas Tasimacilik ve Lojistik Ticaret AS
IS:RYSAS
|
Turkey | TL13.23 Billion |
|
Tansun Technology Co Ltd
SHE:300872
|
China | CN¥1.30 Billion |
|
Shanghai Aladdin Biochemical Technology Co. Ltd. A
SHG:688179
|
China | CN¥1.42 Billion |
|
Wuxi Online Offline Communication Information Technology Co. Ltd.
SHE:300959
|
China | CN¥184.80 Million |
|
Shaanxi Heimao Coking Co Ltd
SHG:601015
|
China | CN¥11.98 Billion |
Liability Composition Analysis (1986–2025)
This chart breaks down CONMED Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CONMED Corporation net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CONMED Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CONMED Corporation (1986–2025)
The table below shows the annual total liabilities of CONMED Corporation from 1986 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.29 Billion | -3.79% |
| 2024-12-31 | $1.34 Billion | -8.34% |
| 2023-12-31 | $1.47 Billion | -5.56% |
| 2022-12-31 | $1.55 Billion | +58.28% |
| 2021-12-31 | $980.58 Million | -5.95% |
| 2020-12-31 | $1.04 Billion | -2.07% |
| 2019-12-31 | $1.06 Billion | +50.61% |
| 2018-12-31 | $706.87 Million | -2.71% |
| 2017-12-31 | $726.53 Million | -2.92% |
| 2016-12-31 | $748.41 Million | +41.78% |
| 2015-12-31 | $527.87 Million | +2.12% |
| 2014-12-31 | $516.90 Million | +6.76% |
| 2013-12-31 | $484.19 Million | +1.41% |
| 2012-12-31 | $477.46 Million | +31.71% |
| 2011-12-31 | $362.52 Million | -9.19% |
| 2010-12-31 | $399.21 Million | +4.78% |
| 2009-12-31 | $380.99 Million | -4.74% |
| 2008-12-31 | $399.93 Million | +2.82% |
| 2007-12-31 | $388.95 Million | -7.66% |
| 2006-12-31 | $421.22 Million | -6.56% |
| 2005-12-31 | $450.78 Million | +6.10% |
| 2004-12-31 | $424.84 Million | +14.34% |
| 2003-12-31 | $371.57 Million | +4.61% |
| 2002-12-31 | $355.20 Million | -15.02% |
| 2001-12-31 | $417.97 Million | -6.90% |
| 2000-12-31 | $448.97 Million | -0.43% |
| 1999-12-31 | $450.90 Million | +0.96% |
| 1998-12-31 | $446.60 Million | +11.96% |
| 1997-12-31 | $398.90 Million | +3368.70% |
| 1996-12-31 | $11.50 Million | -74.10% |
| 1995-12-31 | $44.40 Million | +133.68% |
| 1994-12-31 | $19.00 Million | -4.04% |
| 1993-12-31 | $19.80 Million | +518.75% |
| 1992-12-31 | $3.20 Million | -25.58% |
| 1991-12-31 | $4.30 Million | -54.26% |
| 1990-12-31 | $9.40 Million | -18.97% |
| 1989-12-31 | $11.60 Million | +346.15% |
| 1988-12-31 | $2.60 Million | -10.34% |
| 1987-12-31 | $2.90 Million | +16.00% |
| 1986-12-31 | $2.50 Million | -- |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation an… Read more